Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Cohen

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
JCI Insight|January 25, 2022
Liquid biopsy reveals collateral tissue damage in cancerAsael Lubotzky, Hai Zemmour, Daniel Neiman, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 5, 2026
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide ImagesBrittany McKelvey, Pedro A Torres-Saavedra, Jessica Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2002
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophreniaIlya Chumakov, Marta Blumenfeld, Oxana Guerassimenko, et al.
European Urology|February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
JCI Insight|January 25, 2022
Liquid biopsy reveals collateral tissue damage in cancerAsael Lubotzky, Hai Zemmour, Daniel Neiman, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 5, 2026
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide ImagesBrittany McKelvey, Pedro A Torres-Saavedra, Jessica Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2002
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophreniaIlya Chumakov, Marta Blumenfeld, Oxana Guerassimenko, et al.
European Urology|February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 28